Senti Biosciences Holdings, Inc.

Senti Biosciences Holdings, Inc. (Nasdaq: SNTI) is a clinical-stage biotechnology company that entered the public markets through a business combination with Dynamics Special Purpose Corp., a blank-check vehicle sponsored by Dynamics Special Purpose Sponsor, LLC that completed its initial public offering in 2021. The company develops proprietary engineered gene circuits intended to power next-generation cell and gene therapies, with an initial therapeutic focus on oncology. An 8-K was filed with the SEC on June 7, 2022, reporting a material event in the company's post-merger operations as a newly listed public entity. To access full filing histories, sponsor profiles, and deal analytics for SNTI and the broader SPAC universe, sign up for SpacDesk.